Molecular imaging of tucatinib-induced cellular and TME changes in preclinical models of HER2 + breast cancer.

Saved in:
Bibliographic Details
Title: Molecular imaging of tucatinib-induced cellular and TME changes in preclinical models of HER2 + breast cancer.
Authors: Song PN; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA.; Graduate Biomedical Sciences, The University of Alabama at Birmingham, Birmingham, USA., Mansur A; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA., Gallegos CA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA., Ghanate P; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA., Lapi SE; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA.; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA., Sorace AG; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA. asorace@uabmc.edu.; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA. asorace@uabmc.edu.; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. asorace@uabmc.edu.; Advanced Medical Imaging Research Division Radiology, Department of Radiology and Biomedical Engineering, The University of Alabama at Birmingham, 1670 University Blvd, Birmingham, Alabama, 35233, USA. asorace@uabmc.edu.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2026 Mar 13; Vol. 216 (3). Date of Electronic Publication: 2026 Mar 13.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7217
DOI:10.1007/s10549-026-07936-2